327 related articles for article (PubMed ID: 2109652)
1. Inhibition of liver microsome-mediated mutagenesis, metabolism and DNA-binding of benzo[a]pyrene and benzo[a]pyrene 7,8-dihydrodiol in the rat following glucose administration.
Vance RE; Teel RW; Strother A
Cancer Lett; 1990 Apr; 50(2):149-56. PubMed ID: 2109652
[TBL] [Abstract][Full Text] [Related]
2. Chinese medicinal herbs modulate mutagenesis, DNA binding and metabolism of benzo[a]pyrene 7,8-dihydrodiol and benzo[a]pyrene 7,8-dihydrodiol-9,10-epoxide.
Wong BY; Lau BH; Teel RW
Cancer Lett; 1992 Feb; 62(2):123-31. PubMed ID: 1540939
[TBL] [Abstract][Full Text] [Related]
3. Effect of glucose administration on hamster liver S9-mediated mutagenesis, metabolism and DNA-binding of benzo[a]pyrene and aflatoxin B1.
Rubano DC; Teel RW; Strother A
Cancer Lett; 1990 Jul; 52(2):123-31. PubMed ID: 2116220
[TBL] [Abstract][Full Text] [Related]
4. Effect of tannic acid on rat liver S9 mediated mutagenesis, metabolism and DNA binding of benzo[a]pyrene.
Vance RE; Teel RW
Cancer Lett; 1989 Sep; 47(1-2):37-44. PubMed ID: 2517593
[TBL] [Abstract][Full Text] [Related]
5. Benzo[a]pyrene metabolism and DNA adduct formation mediated by English sole liver enzymes.
Nishimoto M; Varanasi U
Biochem Pharmacol; 1985 Jan; 34(2):263-8. PubMed ID: 4038451
[TBL] [Abstract][Full Text] [Related]
6. Differences in the DNA adducts formed in cultured rabbit and rat dermal fibroblasts by benzo(a)pyrene and (-)benzo(a)pyrene-7,8-diol.
Alexandrov K; Sala M; Rojas M
Cancer Res; 1988 Dec; 48(24 Pt 1):7132-9. PubMed ID: 3142683
[TBL] [Abstract][Full Text] [Related]
7. Instability of (+/-)-7 beta,8 alpha-dihydroxy-9 beta,10 beta-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (syn-BaPDE)-DNA adducts formed in benzo[a]pyrene-treated Wistar rat embryo cell cultures.
Pruess-Schwartz D; Mauthe RJ; Baird WM
Carcinogenesis; 1988 Oct; 9(10):1863-8. PubMed ID: 3139320
[TBL] [Abstract][Full Text] [Related]
8. Catechol-induced alterations in metabolic activation and binding of enantiomeric and racemic 7,8-dihydroxy-7,8-dihydrobenzo[a]pyrenes to DNA in mouse skin.
Melikian AA; Bagheri K; Goldin BF; Hoffmann D
Carcinogenesis; 1989 Oct; 10(10):1863-70. PubMed ID: 2507188
[TBL] [Abstract][Full Text] [Related]
9. Identification and quantitation of benzo[a]pyrene-DNA adducts formed by rat liver microsomes in vitro.
Devanesan PD; RamaKrishna NV; Todorovic R; Rogan EG; Cavalieri EL; Jeong H; Jankowiak R; Small GJ
Chem Res Toxicol; 1992; 5(2):302-9. PubMed ID: 1643262
[TBL] [Abstract][Full Text] [Related]
10. Topical treatment of mice with benzo[a]pyrene or parenteral administration of benzo[a]pyrene diol epoxide-DNA to rats results in faecal excretion of a putative benzo[a]pyrene diol epoxide-deoxyguanosine adduct.
Tierney B; Martin CN; Garner RC
Carcinogenesis; 1987 Sep; 8(9):1189-92. PubMed ID: 3113751
[TBL] [Abstract][Full Text] [Related]
11. The time-dependent increase in the binding of benzo[a]pyrene to DNA through (+)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide in primary rat hepatocyte cultures results from induction of cytochrome P450IA1 by benzo[a]pyrene treatment.
Eberhart J; Coffing SL; Anderson JN; Marcus C; Kalogeris TJ; Baird WM; Park SS; Gelboin HV
Carcinogenesis; 1992 Feb; 13(2):297-301. PubMed ID: 1740021
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of microsome-mediated binding of benzo[a]pyrene to DNA by flavonoids either in vitro or after dietary administration to rats.
Le Bon AM; Siess MH; Suschetet M
Chem Biol Interact; 1992 Jun; 83(1):65-71. PubMed ID: 1643669
[TBL] [Abstract][Full Text] [Related]
13. Use of a microsome-mediated test system to assess efficacy and mechanisms of cancer chemopreventive agents.
Smith WA; Gupta RC
Carcinogenesis; 1996 Jun; 17(6):1285-90. PubMed ID: 8681444
[TBL] [Abstract][Full Text] [Related]
14. Expression of human glutathione S-transferase P1 confers resistance to benzo[a]pyrene or benzo[a]pyrene-7,8-dihydrodiol mutagenesis, macromolecular alkylation and formation of stable N2-Gua-BPDE adducts in stably transfected V79MZ cells co-expressing hCYP1A1.
Kushman ME; Kabler SL; Fleming MH; Ravoori S; Gupta RC; Doehmer J; Morrow CS; Townsend AJ
Carcinogenesis; 2007 Jan; 28(1):207-14. PubMed ID: 16885195
[TBL] [Abstract][Full Text] [Related]
15. Southern flounder hepatic and intestinal metabolism and DNA binding of benzo[a]pyrene (BaP) metabolites following dietary administration of low doses of BaP, BaP-7,8-dihydrodiol or a BaP metabolite mixture.
James MO; Schell JD; Boyle SM; Altman AH; Cromer EA
Chem Biol Interact; 1991; 79(3):305-21. PubMed ID: 1913975
[TBL] [Abstract][Full Text] [Related]
16. DNA adduct formation in mouse tissues in relation to serum levels of benzo(a)pyrene-diol-epoxide after injection of benzo(a)pyrene or the diol-epoxide.
Ginsberg GL; Atherholt TB
Cancer Res; 1990 Feb; 50(4):1189-94. PubMed ID: 2105163
[TBL] [Abstract][Full Text] [Related]
17. Modulation of cytochrome P-450IA1-mediated mutagenicity, DNA binding and metabolism of benzo[a]pyrene by Chinese medicinal herbs.
Wong BY; Lau BH; Yamasaki T; Teel RW
Cancer Lett; 1993 Jan; 68(1):75-82. PubMed ID: 8422652
[TBL] [Abstract][Full Text] [Related]
18. Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons.
Shimada T; Martin MV; Pruess-Schwartz D; Marnett LJ; Guengerich FP
Cancer Res; 1989 Nov; 49(22):6304-12. PubMed ID: 2509067
[TBL] [Abstract][Full Text] [Related]
19. Product inhibition of benzo[a]pyrene metabolism in uninduced rat liver microsomes: effect of diol epoxide formation.
Keller GM; Christou M; Pottenger LH; Wilson NM; Jefcoate CR
Chem Biol Interact; 1987 Feb; 61(2):159-75. PubMed ID: 3103934
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of benzo(a)pyrene and benzo(a)pyrene-trans-7,8-diol metabolism and DNA binding in mouse lung explants by ellagic acid.
Dixit R; Teel RW; Daniel FB; Stoner GD
Cancer Res; 1985 Jul; 45(7):2951-6. PubMed ID: 4039974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
